Hemophilic joint disease - current perspective and potential future strategies

Transfusion and Apheresis Science

Volumn 38, Issue 1, 2008, Pages 49-55

  Acharya, Suchitra S ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Arthropathy; Hemarthroses; Hemophilia; Joint disease; Prophylactic factor replacement; Synovitis; Vascularity

Indexed keywords

BLOOD CLOTTING FACTOR CONCENTRATE; CHROMIUM PHOSPHATE P 32; IRON; PROTEIN MDM2;

ARTHROPATHY; ARTHROPLASTY; ARTICLE; DRUG DOSE ESCALATION; HEMATOLOGIC DISEASE; HEMOPHILIC JOINT DISEASE; HUMAN; ONCOGENE C MYC; PATHOGENESIS; PROPHYLAXIS; SYNOVECTOMY; SYNOVITIS;

HEMOPHILIA A; HUMANS; JOINT DISEASES; MAGNETIC RESONANCE IMAGING;

EID: 40849130634     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2007.12.006     Document Type: Article

References (39)

1. Heyworth B.E., Su E.P., Figgie M.P., Acharya S.S., and Sculco T.P. Orthopedic management of hemophilia. Am J Orthop 34 10 (2005) 479-486
2. Resnick D. Bleeding disorders. In: Resnick D., and Niwayama G. (Eds). Diagnosis of bone and joint disorders (1989), Saunders, Philadelphia 715-724
3. Soreff J., and Blomback M. Arthropathy in children with severe hemophilia A. Acta Paediatr Scand 69 (1980) 667-673
4. Rodriguez-Merchan E.C. Pathogenesis, early diagnosis and prophylaxis for chronic hemophilic synovitis. Clin Orthop 343 (1997) 6-11
5. Luck J.V., and Kasper C.K. Surgical management of advance hemophilic arthropathy. An overview of 20 years' experience. Clin Orthop 242 (1989) 60-82
6. Madhok R., Bennett D., Sturrock R.D., and Forbes C.D. Mechanisms of joint damage in an experimental model of hemophilic arthritis. Arthritis Rheum 31 (1988) 1148-1155
7. Ehrenforth S., Kreutz W., and Scharrer I. Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet 339 (1992) 594-598
8. Lusher J.M. Thrombogenecity associated with factor IX complex concentrates. Semin Hematol 28 (1993) 3-5
9. Nilsson I.M., Hedner U., and Ahlberg A. Hemophilia prophylaxis in Sweden. Acta Paeditr Scand 65 (1976) 129-135
10. Blanchette V.S., Al-Musa A., Stain A.M., Ingram J., and Fille R.M. Central venous access devices in children with hemophilia: an update. Blood Coagul Fibrinol 8 Suppl 1 (1997) S11-S14
11. Manco-Johnson M.J., Nuss R., Geraghty S., Funk S., and Kilcoyne R. Results of secondary prophylaxis in children with severe hemaophilia. Am J hematol 47 (1994) 113-117
12. Fischer K., and Van den Berg M. Prophylaxis for severe hemophilia: clinical and economical issues. Haemophilia 9 (2003) 376-381
13. Nuss R., Kilcoyne R.F., Geraghty S., Shroyer A.L.W., Rosky J.W., Mawhinney S., Wiedel J., and Manco-Johnson M. MRI findings in haemophilic joints treated with radiosynovioorthesis with development of an MRI scale of joint damage. Hemophilia 6 (2000) 162-169
14. Arnold W.D., and Hilgartner M.W. Hemophilic arthropathy: current concepts of pathogenesis and management. J Bone Joint Surg 59 (1977) 287-305
15. Morris C.J., Blake D.R., Wainwright A.C., and Steven M.M. Relationship between iron deposits and tissue damage in the synovium: an ultrastructural study. Ann Rheum Dis 45 (1986) 21-26
16. Roosendaal G., Vianen M.E., Wenting M.J., et al. Iron deposits and catabolic properties of synovial tissue from patients with haemophilia. J Bone Joint Surg Br 80 3 (1998) 540-545
17. Hooiveld M., Roosendaal G., Vianen M., et al. Blood-induced joint damage: long-term effects in vitro and in vivo. J Rheumatol 30 2 (2003) 339-344
18. Roosendaal G., Vianen M.E., Marx J.J.M., Van Den Berg H.M., et al. Blood-induced joint damage: a human in vitro study. Arthritis Rheumat 42 5 (1999) 1025-1032
19. Wen F.Q., Jabbar A.A., Chen Y.X., Kazarian T., et al. c-myc proto-oncogene expression in hemophilic synovitis: in vitro studies of the effects of iron and ceramide. Blood 100 (2002) 912-916
20. Hakobyan N., Kazarian T., Jabbar A.A., Jabbar K.J., and Valentino L.A. Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene. Blood 104 (2004) 2060-2064
21. Folkman J., and Shing Y. Angiogenesis. J Biol Chem 267 (1992) 10931-10934
22. Greene W., Yankaska B., and Guilford W. Roentgenographic classification of hemophilic arthropathy. J Bone Joint Surg 2 (1989) 237-244
23. Idy-Pereti I., Le Balc'h T., Yvart J., and Bittoun J. MR imaging of hemophilic arthropathy of the knee: classification and evolution of the subchondral cysts. Magnet Res Imag 10 (1992) 67-75
24. Nuss R., Kilcoyne R.F., Geraghty S., Wiedel J., and Manco-Johnson M. Utility of magnetic resonance imaging for management of hemophilic arthropathy in children. J Pediatr 123 3 (1993) 388-392
25. Ostergaard M., Ejbjerg B., Stoltenberg M., Gideon P., Volck B., Skov K., Jensen C.H., and Lorenzen I. Quantitative magnetic resonance imaging as marker of synovial membrane regeneration and recurrence of synovitis after arthroscopic knee joint synovectomy: a one year follow up study. Ann Rheum Dis 60 3 (2001) 233-236
26. Merchan E.C., De Orbe A., and Gago J. Ultrasound in the diagnosis of the early stages of hemophilic arthropathy of the knee. Acta Orthop Belg 58 (1992) 122-125
27. Doria A.S., Kiss M.H., Lotito A.P., Molnar L.J., et al. Juvenile rheumatoid arthritis of the knee: evaluation with contrast-enhanced Doppler ultrasound. Pediatr Radiol 31 7 (2001) 524-531
28. Klukowska A., Czyrny Z., Laguna P., Brzewski M., et al. Correlation between clinical, radiological and ultrasonographical image of knee joints in children with haemophilia. Haemophilia 7 (2001) 286-292
29. Fischer K., Van der Bom J.G., Mauser Bunschoten E.P., Roosendaal G., et al. The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia. Blood 99 7 (2002) 2337-2341
30. Berntorp E., and Michiels J.J. A healthy hemophilic patient without arthropathy: from concept to reality. Semin Thromb Hemost 29 1 (2003) 5-10
31. Feldman B., Pai M., Rivard G.E., Israels S., et al. Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian hemophilia primary prophylaxis study. J Thromb Haemost 4 6 (2006) 1228-1236
32. Donadel Claeysseus on behalf of the European Network for Haemophilia management. Current coordinated activities of the PEDNET (European Pediatric Network for Haemophilia Management) Haemophilia 2006; 12: 124-7.
33. Kern M., Blanchette V., Stain A.M., et al. Clinical and cost implication of target joints in Canadian boys with severe hemophilia A. J Pediatr 145 (2004) 628-634
34. Journeycake J.M., Miller K.L., Anderson A.M., Buchanan G.R., and Finnegan M. Arthroscopic synovectomy in children and adolescents with hemophilia. J Pediatr Hematol Oncol 25 (2003) 726-731
35. Dunn A.L., Busch M.T., Wyly J.B., Sullivan K.M., and Abshire T.C. Arthroscopic synovectomy for hemophilic joint disease in a pediatric population. J Pediatr Orthop 24 (2004) 414-426
36. Dunn A.L., Manco-Johnson M., Busch M.T., Balark K.L., and Abshire T.C. Leukemia and P32 radionuclide synovectomy for hemophilic arthropathy. J Thromb Haemost 3 7 (2005) 1541-1542
37. Hilberg T., Herbsleb M., Puta C., Gabriel H.H., Schramm W., Herbsleb M., Puta C., Gabriel H.H., and Schramm W. Haemophilia 9 1 (2003) 86-93
38. Harris S., and Boggio L.N. Exercise may decrease further destruction in the adult haemophilic joint. Haemophilia 3 (2006) 237-240
39. Beeton K., Rodriguez-Merchan E.C., and Alltree J. Total joint arthroplasty in haemophilia. Haemophilia 6 (2000) 474-481